Gossamer Bio is trading 5.41% up at $11.31 amid broader risk-on sentiment; no new company-specific announcement was identified for September 21, 2026.
- The S&P 500, NASDAQ Composite, and Dow Jones were each up more than 0.5% in pre-market trading.
- Recent corporate developments, including the 1-for-80 reverse stock split, remain background context rather than a fresh catalyst.